Drug Profile
Iodine-124-AVP 0458
Alternative Names: 124I-PEG-AVP04; AVP-04 - Avipep; AVP-4; I124-AVP 04Latest Information Update: 28 Dec 2017
Price :
$50
*
At a glance
- Originator Avipep
- Class Antibody diagnostics; Imaging agents; Polyethylene glycols; Radiopharmaceutical diagnostics; Radiopharmaceuticals
- Mechanism of Action Positron-emission tomography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Ovarian cancer; Prostate cancer
Most Recent Events
- 28 Dec 2017 No recent reports of development identified for phase-I development in Ovarian-cancer(Diagnosis) in Australia (IV, Infusion)
- 28 Dec 2017 No recent reports of development identified for phase-I development in Prostate-cancer(Diagnosis) in Australia (IV, Infusion)
- 29 Aug 2012 Phase-I clinical trials in Ovarian cancer (Diagnosis) in Australia (IV)